1. Home
  2. KURA vs NTB Comparison

KURA vs NTB Comparison

Compare KURA & NTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KURA
  • NTB
  • Stock Information
  • Founded
  • KURA 2014
  • NTB 1858
  • Country
  • KURA United States
  • NTB Bermuda
  • Employees
  • KURA N/A
  • NTB 1334
  • Industry
  • KURA Biotechnology: Biological Products (No Diagnostic Substances)
  • NTB Commercial Banks
  • Sector
  • KURA Health Care
  • NTB Finance
  • Exchange
  • KURA Nasdaq
  • NTB Nasdaq
  • Market Cap
  • KURA 793.2M
  • NTB 1.6B
  • IPO Year
  • KURA N/A
  • NTB 2016
  • Fundamental
  • Price
  • KURA $7.26
  • NTB $36.40
  • Analyst Decision
  • KURA Strong Buy
  • NTB Buy
  • Analyst Count
  • KURA 11
  • NTB 6
  • Target Price
  • KURA $27.89
  • NTB $39.67
  • AVG Volume (30 Days)
  • KURA 1.8M
  • NTB 210.3K
  • Earning Date
  • KURA 02-25-2025
  • NTB 02-10-2025
  • Dividend Yield
  • KURA N/A
  • NTB 4.86%
  • EPS Growth
  • KURA N/A
  • NTB N/A
  • EPS
  • KURA N/A
  • NTB 4.50
  • Revenue
  • KURA N/A
  • NTB $573,100,000.00
  • Revenue This Year
  • KURA N/A
  • NTB N/A
  • Revenue Next Year
  • KURA $233.30
  • NTB N/A
  • P/E Ratio
  • KURA N/A
  • NTB $7.89
  • Revenue Growth
  • KURA N/A
  • NTB N/A
  • 52 Week Low
  • KURA $6.98
  • NTB $28.73
  • 52 Week High
  • KURA $24.17
  • NTB $40.55
  • Technical
  • Relative Strength Index (RSI)
  • KURA 17.38
  • NTB 47.68
  • Support Level
  • KURA $6.98
  • NTB $34.77
  • Resistance Level
  • KURA $8.88
  • NTB $37.13
  • Average True Range (ATR)
  • KURA 0.33
  • NTB 0.78
  • MACD
  • KURA 0.05
  • NTB -0.06
  • Stochastic Oscillator
  • KURA 13.40
  • NTB 60.26

About KURA Kura Oncology Inc.

Kura Oncology Inc is a clinical-stage biopharmaceutical company, that engages in discovering and developing therapeutics for the treatment of solid tumors and blood cancers. It focuses on the development of small-molecule product candidates that target cell signaling pathways to drive the progression of various cancers. The company has a product candidate, Tipifarnib, which is a farnesyl transferase inhibitor, in both solid tumors and blood cancers. Geographically operation of the group is carried through the United States.

About NTB Bank of N.T. Butterfield & Son Limited (The) Voting

Bank of N.T Butterfield & Son Ltd is a full-service bank and wealth manager. It operates the business through three geographic segments, Bermuda, the Cayman Islands, the Channel Islands, and the UK. The company offers banking services, comprised of retail and corporate banking, and wealth management, which consists of trust, private banking, and asset management. The company generates a majority of its revenue from Bermuda, and the Cayman Islands segments.

Share on Social Networks: